Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jinil Han"'
Autor:
Jai Min Ryu, Soo Youn Cho, Jonghan Yu, Se Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Jinil Han, Seok Won Kim, Byung Joo Chae, Jee Hyun Ahn, Jun Hee Lee
The GenesWell™ BCT (BCT score) is a recently developed multigene assay that predicts the risk of distant recurrence in patients with hormone receptor-positive (HR+) and HER2 negative (HER2-) early breast cancer (BC). The ability of the assay to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5be4ebfcdd11b6ffaa032a93ec5dbd7
https://doi.org/10.21203/rs.3.rs-523729/v1
https://doi.org/10.21203/rs.3.rs-523729/v1
Autor:
Yu-Jin Kim, Gyunghwa Lee, Jinil Han, Kyoung Song, Joon-Seok Choi, Yoon-La Choi, Young Kee Shin
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2020)
Frontiers in Oncology, Vol 9 (2020)
We previously showed that UBE2C mRNA expression is significantly associated with poor prognosis only in patients with hormone receptor (HR)+/human epidermal growth factor receptor 2 (HER2)– breast cancer. In this study, we further reanalyzed the co
Autor:
Mi Jeong Kwon, Jeong Eon Lee, Joon Jeong, Sang Uk Woo, Jinil Han, Byeong-il Kang, Jee-Eun Kim, Youngho Moon, Sae Byul Lee, Seonghoon Lee, Yoon-La Choi, Youngmi Kwon, Kyoung Song, Gyungyub Gong, Young Kee Shin
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Introduction: The GenesWell Breast Cancer Test (BCT) is a recently developed multigene assay that predicts the risk of distant recurrence in patients with early breast cancer. Here, we analyzed the concordance of the BCT score with the Oncotype DX re
Autor:
Byung-Ho Nam, Jeong Eon Lee, Jong Won Lee, Gyungyub Gong, Peter D Beitsch, Sei Hyun Ahn, Jinil Han, Mi Jeong Kwon, Seok Jin Nam, Sae Byul Lee, Young Kee Shin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 11, p e0207155 (2018)
PLoS ONE, Vol 13, Iss 11, p e0207155 (2018)
The Breast Cancer Test (BCT) score has been validated for its ability to predict the risk of distant metastasis in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer. This study aimed to examine th
Autor:
Jeong Eon Lee, Haein Kim, Jinil Han, Joon Seok Choi, Sarah Park, Young Kee Shin, Yoon-La Choi, Jong Sun Choi, Byung-Ho Nam, Seok Jin Nam, Jun Young Choi, Se Kyung Lee, Young Deug Kim, Mi Jeong Kwon
Publikováno v:
Breast Cancer Research and Treatment
Purpose More accurate prediction of patient outcome based on molecular subtype is required to identify patients who will benefit from specific treatments. Methods We selected novel 16 candidate prognostic genes, including 10 proliferation-related gen